Nippon Shokubai Joins Convertible Funding Round at PURMX Therapeutics

Nippon Shokubai has joined a convertible funding round at biotech startup PURMX Therapeutics, per a Dealroom.co record, extending the Japanese chemicals maker's reach into life sciences.